U.S.-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: Standardization and validation of laboratory procedures

Communications in Clinical Cytometry

Volumn 30, Issue 5, 1997, Pages 214-230

  Stelzer, Gregory T ^a   Marti, Gerald ^b   Hurley, Anne ^c   McCoy Jr , Phil ^d   Lovett, E J ^e   Schwartz, Abe ^f  

^a Cytometry Associates Inc   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^c Comprehensive Cytometric Consulting ^*  (United States)

^d Department of Anesthesiology   (United States)

^e Maine Medical Center Research Institute   (United States)

^f Flow Cytometry Standards Corporation   (Puerto Rico)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY;

CANADA; CELL VIABILITY; CONFERENCE PAPER; FLOW CYTOMETRY; HEMATOLOGIC DISEASE; HUMAN; IMMUNOFLUORESCENCE; IMMUNOPHENOTYPING; LABORATORY DIAGNOSIS; LABORATORY TEST; LEUKEMIA; LYMPHOMA; NEOPLASM; PRIORITY JOURNAL; QUALITY CONTROL; STANDARDIZATION; UNITED STATES;

CANADA; CELL SURVIVAL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA; QUALITY CONTROL; SPECIMEN HANDLING; UNITED STATES;

EID: 0030840151     PISSN: 01964763     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0320(19971015)30:5<214::AID-CYTO2>3.0.CO;2-H     Document Type: Conference Paper

References (87)

1. Afar B, Merrill J, Clark E: Detection of lymphocyte subsets using three-color/single laser flow cytometry and the fluorescent dye peridinin chlorophyll-A protein. J Clin Immunol 11:254-261, 1991.
2. Almasri N, Daque R, Iturraspe J, Everett E, Braylan R: Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am J Hematol 40:259, 1992.
3. Bernard A, Boumsell L, Dausset J, Milstein C, Schlossman S: Leukocyte Typing. Report on the First International Reference Workshop sponsored by INSERM, WHO and IUIS. Springer-Verlag, Berlin, 1984.
4. Borowitz M, Guenther K, Shults K, Stelzer G: Immunophenotyping of acute leukemia by flow cytometric analysis. Am J Clin Path 100:534-540, 1993.
5. Brando B, Sommaruga E: Nationwide quality control trial on lymphocyte phenotyping and flow cytometry performance in Italy. Cytometry 14:294-306, 1993.
6. Braylan R, Benson N: Flow cytometric analysis of lymphomas. Arch Pathol Lab Med 113:627, 1989.
7. Braylan R, Benson N, Benson B, Nourse V: Analysis of neoplastic leukocyte surface antigens in unfractionated blood. Ann NY Acad Sci 468:160-170, 1986.
8. Cardwell C, Maggi J, Henry L, Taylor H: Fluorescence intensity as a quality control parameter in clinical flow cytometry. Am J Clin Path 188:447-456, 1987.
9. Carey J, Hanson C: Flow cytometric analysis of leukemia and lymphoma In: Flow Cytometry and Clinical Diagnosis, Keren D, Hanson C, Hurtubise P (eds). American Society of Clinical Pathologists, Chicago, 1994, pp 197-308.
10. Carter P, Resto-Ruiz S, Washington G, Ethridge S, Palini A, Vogt R, Waxdal M, Fleischer T, Noguchi P, Marti G: Flow cytometric analysis of whole blood lysis, three anticoagulants, and five cell preparations. Cytometry 13:68-74 1992.
11. Cavelli T, Denny T, Paxton H, Gelman R, Kagan J: Guideline for flow cytometric immunophenotyping: A report from the National Institute of Allergy and infectious Diseases, Division of AIDS. Cytometry 14:702-715, 1993.
12. Clevenger C, Shankey T: Cytochemistry II: Immunofluorescence measurement of intracellular antigens. In: Clinical Flow Cytometry: Principles and Application. Bauer K, Duque R, Shankey T (eds). Williams & Wilkins, Baltimore, 1993, PP 157-175.
13. Clinical Laboratory Improvement Act, 1988. Code of Federal Regulations, Title 42: Sec 1213.
14. De Paoli P, Villalta D, Battistin S, Gasparollo A, Santini G: Selective loss of OKT8 lymphocytes on density gradient centrifugation separation of blood mononuclear cells. J Immunol Meth 61:259-260, 1983.
15. Duque R, Andreeff M, Braylan R, Diamond L, Peiper S: Consensus review of the clinical utility of DNA flow cytometric in neoplastic hematopathology. Cytometry 14:492-496, 1993.
16. Francis C, Connelly M: Rapid single-step method for flow cytometric detection of surface and intracellular antigens using whole blood. Cytometry 25:58-70, 1996.
17. Fukushima P, Nguyen P, O'Grady P, Stetler-Stevenson M: Flow cytometric analysis of kappa and lambda light chain expression in evaluation of specimens for B-cell neoplasia. Cytometry (Comm Clin Cytometry) 26:243-252, 1996.
18. Geisler C, Larsen J, Hansen N, Hansen M, Christensen B, Lund B, Nielsen H, Plesner T, Thorling K, Andersen A: Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell CLL. Blood 78:1795-1802, 1991.
19. Groeneveld K, te Marvelde J, van den Beemd M, Hooijkaas H, van Dongen J: Flow cytometric determination of intracellular antigens for immunophenotyping. Leukemia 10:1383-1389, 1996.
20. Hurwitz C, Loken M, Graham M, Karp J, Borowitz M, Pullen D, Civin C: Asynchronous antigen expression in B lineage acute lymphoblastic leukemia. Blood 72:299-307, 1988.
21. Immunophenotyping of Leukemic Cells: Proposed Guidelines. NCCLS; Villanova, PA, 1993.
22. Islam D, Lindberg A, Christensson B: Peripheral blood cell preparation influences the level of expression of leukocyte cell surface markers as assessed with quantitative multicolor fluorescence. Cytometry 22:128-134, 1995.
23. Janossy G, Coustan-Smith E, Campana D: The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: A study of 500 cases. Leukemia 3:170-181, 1989.
24. King M, Wells J: Cell-bound immunoglobulin on peripheral blood mononuclear cells of patients with myeloma. Clin Exp Immunol 45:552-556, 1981.
25. Knapp W, et al. Leukocyte Typing IV. Proceedings of the fourth International Workshop and Conference on Human Leukocyte Differentiation Antigens. Oxford University Press, Oxford, 1989.
26. Knapp W, Majdic O, Strobl H: Flow cytometric analysis of intracellular myeloperoxidase and lactoferrin in leukemia diagnosis In: Recent Results in Cancer Research, Ludwig W, Thiel E (eds). Springer-Verlag, Berlin, 1993, pp 32-40.
27. Knapp W, Strobl H, Majdic O: Flow cytometric analysis of cell surface and intracellular antigens in leukemia diagnosis. Cytometry (Comm Clin Cytometry) 18:187-198, 1994.
28. Krishan A, Ganapathi R: Laser flow cytometric studies on intracellular fluorescence of antracyclines. Cancer Res 40:3895-3900, 1980.
29. Krishan A, Sridhar K, Davila E, Vogel C, Sternheim W: Patterns of antracycline retention modulation in human tumor cells. Cytometry 8:306-314, 1987.
30. Lenkei R, Andersson B: Determination of the antibody binding capacity of lymphocyte membrane antigens by flow cytometry in 58 blood donors. J Immunol Meth 183:267-277, 1995.
31. Letwin B, Wallace P, Muirhead K, Hensler G, Kashatus W, Horan P: An improved clonal excess assay using flow cytometry and B-cell gating. Blood 74:1178-1185, 1990.
32. Lewis D: Cytochemistry I: Cell surface immunofluorescence. In: Clinical Flow Cytometry. Principles and Application, Bauer K, Duque R, Shankey T (eds). Williams & Wilkins, Baltimore, 1993, 143-156.
33. Liu Z, Hultin LE, Cumberland WG, Hultin P, Schmid I, Matud JL, Detels R, Giorgi JV: Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up. Cytometry (Communications in Clinical Cytometry) 26:1-7, 1996.
34. Loken M, Brosnan J, Bach B, Ault K: Establishing optimal lymphocyte gates for immunophenotyping by flow cytometry. Cytometry 11:453-459, 1990.
35. Lopez J, Chew S, Thompson H, Malter J, Insler M, Beureman R: EGF cell surface receptor quantitation on ocular cells by an immunocytochemical flow cytometry technique. Invest Opthalmol Vis Sci 33:2053-2062, 1992.
36. Marti G, Faguet G, Bertin P, Agee J, Washington G, Ruiz S, Carter P, Zenger V, Vogt R, Noguchi P: CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann NY Acad Sci 651:480, 1992.
37. McCoy J, Carey J, Kause J: Quality control in flow cytometry for diagnostic pathology. I. Cell surface immunophenotyping and general laboratory precedures. Am J Clin Path S27-S37, 1990.
38. McMichael A: Leukocyte Typing III. Proceedings of the third International Workshop and Conference on Human Leukocyte Differentiation Antigens. Oxford University Press, Oxford, 1987.
39. Medical Devices; Classification/Reclassification; Restricted Devices; Analyte specific reagents. Federal Register 61: Docket no. 96N-0082, 1996.
40. Molot R, Meeker T, Wittwer C, Perkins S, Segal G, Masih A, Braylan R, Kjeldsberg C: Antigen expression and polymerase chain reaction amplification of mantle cell lymphomas. Blood 83:1626-1631, 1994.
41. Muirhead K: Quality control for clinical flow cytometry. In: Clinical Flow Cytometry: Principles and Applications, Bauer K, Duque R, Shankey T (eds): Williams & Wilkins, Baltimore, 1993. pp 177-199.
42. Muirhead K, Wallace P, Schmitt T, Frescatore R, Franco J, Horan P: Methodological consideration for implementation of lymphocyte subset analysis in a clinical reference laboratory. Ann NY Acad Sci 468:113-127, 1986.
43. Mujumdar R, Ernst L, Mujumdar S, Waggoner A: Cyanine dye labeling reagents containing isothiocyanate groups. Cytometry 10:11-19, 1989.
44. Nicholson J, Kidd P, Mandy F, Livnat D, Kagan J: Three-color supplement to the NIAID DAIDS Guideline for flow cytometric immunophenotyping. Cytometry (Communications in Clinical Cytometry) 26:227-230, 1996.
45. Nicholson J, McDougal J, Hearn T, Collins C, Velleca W, Jones W, Gerber A: CDC 1994 Revised Guidelines for the Performance of CD+ T-Cell Determinations in Persons with Human Immunodeficiency Virus (HIV) Infections. MMWR 43:1-21, 1994.
46. Owens M, Loken M: Flow Cytometry Principles for Clinical Laboratory Practice. Quality Assurance for Quantitative Immunophenotyping. Wiley-Liss, New York, 1995.
47. Paxton H, Bendele T: Effect of time, temperature and anticoagulant on flow cytometry and hematological values. Ann NY Acad Sci 677:440-443, 1993.
48. Pizzolo G, Vincenzi C, Nadali G, Veneri D, Viante F, Chilosi M, Basso G, Connelly M, Janossy G: Detection of membrane and intracellular antigens by flow cytometry following Ortho PermcaFix fixation. Leukemia 8:672-676, 1994.
49. Pollice A. McCoy J, Shackney S, Smith C, Agarwal J, Burholt D, Janocko L, Hornicek F, Singh S, Hartsock R: Sequential paraformalehyde and methanol fixation for simultaneous flow cytometric analysis of DNA. cell surface proteins, and intracellular proteins. Cytometry 13:432-444, 1992.
50. Poon R, Fernandez-Repollet E, Vogt R, Gratama J: Characterization of available standards for flow cytomtry. Flow Cytometry Standardization Forum 6:1-4, 1993.
51. Poon R, Johnson R, Stanton T, Fernandez-Repollet E, Schwartz A: Calibration of fluorescence intensity microbead standards and assignment of effective F:P ratios to the FITC-conjugated secondary antibody used in the Vth International Leukocyte Typing Workshop In: Leukocyte Typing V. Proceedings of the fifth International Workshop and Conference on Human Leukocyte Differentiation Antigens, Schlossman S, et al. (eds): Oxford University Press, Oxford, 1995, pp 13-16.
52. Quality Assurance and Immunophenotyping of Peripheral Blood Lymphocytes. NCCLS, Villanova, PA, 1991.
53. Rainer R, Hodges L, Stelzer G: CD45 gating correlates with bone marrow differential. Cytometry 22:139-145, 1995.
54. Recktenwald D, Prezelin B, Chen C, Kimura J: Biological pigments as fluorescent labels for cytometry. In: New Technologies in Cytometry and Molecular Biology, 1206th, Salzman G (ed). SPIE, 1990, 106-111.
55. Reinherz E, Haynes B, Nadler L, Bernstein I: Leukocyte Typing II. Papers presented at the Second International Workshop on Human Leukocyte Differentiation Antigens. Springer-Verlag, New York, 1986.
56. Renzi P, Ginns L: Analysis of T-cell subsets in normal adults: Comparison of whole blood lysis technique to ficoll-hypaque separation by flow cytometry. J Immunol Meth 98:53-56, 1987.
57. Reynolds W, Williamson A, Smith G, Lane A: A simple technique for the determination of k and I immunoglobulin light chain expression by B-cells in whole blood. J Immunol Meth 151:123-129, 1992.
58. Riedy M, Muirhead K, Jensen C, Stewart C: Use of a photolabeling technique to identify nonviable cells in fixed homologous or heterologous cell populations. Cytometry 12:133-139, 1991.
59. Roth G, Schmitz G: Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working group on flow cytometry and image analysis. Leukemia 10:877-895, 1996.
60. Sasaki D, Bumas S, Engleman E: Discrimination of viable and nonviable cells using propidium iodide in two color immunofluorescence. Cytometry 8:413-420, 1987.
61. Schlossman S, et al. Leukocyte Typing V. Proceedings of the fifth International Workshop and Conference on Human Leukocyte Differentiation Antigens. Oxford University Press, Oxford, 1995.
62. Schmid I, Krall W, Uittenbogaart C, Braun J, Giorgi J: Dead cell discrimination with 7-amino-actinomycin D in combination with dual color immunofluorescence in single laser flow cytometry. Cytometry 13:204-208, 1992.
63. Schnizlein-Bick C, Magier M, Jones R, Fife K, Katz B, Walker E: Differences among mononuclear cell subpopulations in HIV seropositive or seronegative homosexual and heterosexual men as determined by four-color flow cytometry. J Acquir Immune Defic Syndr 3:747-756, 1990.
64. Schroff R, Bucana C, Klein R: Detection of intracytoplasmic antigens by flow cylometry. J Immunol Meth 70:167-177, 1984.
65. Schwartz A, Fernandez-Repollet E: Development of clinical standards for flow cytometry. Ann NY Acad Sci 667:28-39, 1993.
66. Schwartz A, Fernandez-Repollet E: Standardization for flow cytometry. In: Methods in Cell Biology, 42th, Darzynkiewicz Z, Robinson J, Crissman H (eds). Academic Press, New York, 1994, 605-626.
67. Schwartz A, Fernandez-Repollet E: Technical aspects of fluorescence quantitative measurements by flow cytometry. Clin Immunol Newslett 15:73-77, 1995.
68. Schwartz A, Fernandez-Repollet E, Vogt R, Gratama J: Standardizing flow cytometry: Construction of a standardized fluorescence calibration plot using matching spectral calibrators. Cytometry (Comm Clin Cytometry) 26:22-31, 1996.
69. Segal G, Masih A, Fox A, Jorgensen T, Scott M, Braylan R: CD5 expressing B-cell non-Hodgkin's lymphomas with bcl-1 gene rearrangement have a relatively homgenous immunophenotype and are associated with an overall poor prognosis. Blood 85:1570-1579, 1995.
70. Self S, Burdash N, Rainer R, LaVia M: Lymphocytes subsets in lymph node hyperplasias and B-cell neoplasms as determined by fluoresceinated antibodies and flow cytometry. Ann NY Acad Sci 468:195-210, 1986.
71. Shankey T, Rabinovitch P, Bagwell B, Bauer K, Daque R, Hedley D, Mayall B, Wheeles L: Guidelines for implementation of clinical DNA cytometry. Cytometry 14:472-477, 1993.
72. Shapiro H: Practical Flow Cytometry, 2nd ed. Wiley-Liss, New York. 1988.
73. Slaper-Cortenbach I, Admiraal L, Kerr J, van Leeuwen E, KR. von dem Borne A, Tetteroo P: Flow cytometric detection of terminal deoxynucleotidyl transferase and other intracellular antigens in combination with membrane antigens in acute lymphatic leukemias. Blood 72:1639-1644, 1988.
74. Southwick P, Ernst L, Tauriello E, Parker SR, Mujumdar RB, Mujumdar SR, Clever HA, Waggoner AS: Cyanine-dye labeling reagents: Carboxymethylindocyanine succinimidyl esters. Cytometry 11:418-430, 1990.
75. Stelzer G, Shults K, Loken M: CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci 677:265-280, 1993.
76. Stewart C: Clinical application of flow cytometry, Immunological methods for measuring cell membrane and cytoplasmic antigens. Cancer 69:1543-1552, 1992.
77. Stewart C, Stewart S: Immunological monitoring utilizing novel probes. Ann NY Acad Sci 677:94-112, 1993.
78. Stewart C, Stewart S: Cell preparation for the identification of leukocytes. In: Methods in Cell Biology, Darzynkiewicz Z, Robinson J, Crissman H (eds). Academic Press, New York. 1994, pp 39-60.
79. Tbakhi A, Edinger M, Myles J, Pohlman B, Tubbs R: Flow cytometric immunophenotyping of non-Hodgkin's lymphomas and related disorders. Cytometry 25:113-124, 1996.
80. Terstappen L, Koneman S, Safford M, Loken M, Zurlutter K, Buchner T, Hiddemann W, Wormann B: Flow cytometric characterization of acute myeloid leukemia: Part II. Phenotypic heterogeneity at diagnosis. Leukemai 6:70-80, 1991.
81. Terstappen L, Loken M: Multi-dimensional flow cytometric characterization of myeloid maturation in normal bone marrow and acute myeloid leukemia. In: Advances in Analytical Cellular Pathology, Burger G, Oberholzer M, Vooijs G, (eds). Excerpta medica, Amsterdam, 1990, pp 209-210.
82. Van't Veer M, Kluin-Nelemans J, Van der Schoot C, Van Putten W, Adriaansen H, Van Wering E: Quality assessment of immunological marker analysis and the immunological diagnosis in leukemia and lymphoma: A multi-centre study. Br J Hematol 80:458-465, 1992.
83. Vogt R, Cross G, Phillips D, Henderson L, Ilannon W: Interlaboratory study of cellular fluorescence intensity measurements with fluorescein-labeled microbead standards. Cytometry 12:525-536, 1991.
84. Vogt R, Marti G, Schwartz A: Quantitative calibration of fluorescence intensity for clinical and research applications of immunopohenotyping by flow cytometry. In: Reviews in Biotechnology and Bioengineering. Vol 1, Tyler H (eds). Ablex, Norwood, NJ, 1994.
85. Waggoner A, Ernst L: Fluorescent reagents for flow cytometry. In: Clinical Flow Cytometry: Principles and Application, Bauer K, Shankey T (eds). Williams & Wilkins, Baltimore, 1993, pp 111-116.
86. Wovzynski MJ, Podgurski AE, Boldt DM, Otto RN: An automated method to prepare cell suspensions from human biopsy samples for immunophenotyping by flow cytometry. Am J Clin Pathol 93:104-108, 1990.
87. Zukerberg L, Medeiros J, Ferry J, Harris N: Diffuse low-grade B-cell lymphomas. Am J Clin Path 100:373-385, 1993.